Generics - Financial, Mergers & Acquisitions


Popular Filters

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal

Abbott Labs sells branded generics business to Mylan in $5.3 billion deal


Following a weekend of rumors and speculation, USA-based generics major Mylan and health care firm Abbott…

Abbott LaboratoriesAustraliaCanadaEuropeFinancialGenericsJapanMergers & AcquisitionsMylanNew Zealand

AMRI to acquire Cedarburg Pharmaceuticals in $41 million deal


Albany Molecular Research, a USA-based contract research and manufacturing organization, has signed a…

Albany Molecular ResearchCedarburg PharmaFinancialGenericsMergers & Acquisitions

Stada Arz buys UK OTC manufacturer


German generic and branded drugmaker Stada Arzneimittel (SAZ: GR) signed and concluded a contract for…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & Ross

Actavis and Warner Chilcott leap on merger talks; possible bid for Adcock Ingram


US generics major Actavis NYSE: ACT) confirmed on Friday (May 10) that it has entered into early stage…

ActavisAdcock IngramFinancialGenericsMergers & AcquisitionsPharmaceuticalWarner Chilcott

Hikma to retain its global Injectables business


Further to its announcement last month that it was undertaking a review of the strategic options for…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Hikma leaps as it confirms unsolicited interest in Injectables business


Jordanian drugmaker Hikma Pharmaceuticals (LSE: HIK) saw its shares jump 8.1% to£9.365 on Friday,…

FinancialGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceutical

Pernix splashes out over $100 million to buy Cypress Pharma and Hawthorn Pharma


US specialty drugmaker Pernix Therapeutics (NYSE: PTX) has entered into a definitive agreement to acquire…

Cypress PharmaceuticalsFinancialGenericsHawthorn PharmaceuticalsMergers & AcquisitionsPernix TherapeuticsPharmaceutical

Fitch puts Watson on rating watch Negative on planned acquisition of Actavis


US generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has seen its rating downgraded by Fitch Ratings,…

ActavisFinancialGenericsMergers & AcquisitionsNorth AmericaWatson Pharmaceuticals

Valeant Pharma to acquire assets in Mexico; Mylan invests in Ireland


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says it has signed an…

Atlantis PharmaEuropeFinancialGenericsMergers & AcquisitionsMylan LaboratoriesSouth AmericaValeant Pharmaceuticals

Flamel Tech acquires US firm Eclat Pharma; reports loss


Lyon, France-based drug delivery firm Flamel Technologies (Nasdaq: FLML) said last week that it has acquired…

Eclat PharmaceuticalsFinancialFlamel TechnologiesGenericsMergers & AcquisitionsPharmaceutical

Watson buys Strides Arcolab unit for A$375 million; 2011 results


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has kicked off the new year with the acquisition…

Ascent PharmahealthAsia-PacificFinancialGenericsMergers & AcquisitionsStrides ArcolabWatson Pharmaceuticals

STADA to buy Spirig generics business for $109 million; posts 9-month loss due to Serbian difficulties


German drugmaker STADA Arzneimittel (SAZ: GR) has reached agreement with Switzerland’s Spirig Pharma…

FinancialGenericsMergers & AcquisitionsPharmaceuticalSpirig PharmaSTADA Arzneimittel

Aurobindo sets up JV with Diod to make and market generic drugs in Russia


Indian drugmaker Aurobindo Pharma (ARBN: BO) and OJSC Diod, a Russian manufacturer of ecological health…

Aurobindo PharmaDiodEuropeFinancialGenericsMarkets & MarketingMergers & Acquisitions

Company Spotlight



Back to top